Abstract:During the last forty years we have witnessed impressive advances in the field of antiviral drug discovery culminating with the introduction of therapies able to stop human immunodeficiency virus (HIV) replication, or cure hepatitis C virus infections in people suffering from liver disease. However, there are important viral diseases without effective treatments, and the emergence of drug resistance threatens the efficacy of successful therapies used today. In this review, we discuss strategies to discover antiviral compounds specifically designed to combat drug resistance. Currently, efforts in this field are focused on targeted proteins (e.g. multi-target drug design strategies), but also on drug conformation (either improving drug positioning in the binding pocket or introducing conformational constraints), in the introduction or exploitation of new binding sites, or in strengthening interaction forces through the introduction of multiple hydrogen bonds, covalent binding, halogen bonds, additional van der Waals forces or multivalent binding. Among the new developments, proteolysis targeting chimeras (PROTACs) have emerged as a valid approach taking advantage of intracellular mechanisms involving protein degradation by the ubiquitin-proteasome system. Finally, several molecules targeting host factors (e.g. human dihydroorotate dehydrogenase and DEAD-box polypeptide 3) have been identified as broad-spectrum antiviral compounds. Implementation of herein described medicinal chemistry strategies are expected to contribute to the discovery of new drugs effective against current and future threats due to emerging and re-emerging viral pandemics.

NMR Spectroscopy Can Help Accelerate Antiviral Drug Discovery Programs

NMR Spectroscopy Can Help Accelerate Antiviral Drug Discovery Programs

NMR as a “Gold Standard” Method in Drug Design and Discovery

The role of NMR in advancing small molecule drug discovery

NMR spectroscopy in drug discovery and development: Evaluation of physico-chemical properties

Accelerating antiviral drug discovery: lessons from COVID-19

Medicinal Chemistry Strategies For Discovering Antivirals Effective Against Drug-Resistant Viruses

Recent progress in fragment-based drug discovery facilitated by NMR spectroscopy

Contemporary Approaches to the Discovery and Development of Broad-Spectrum Natural Product Prototypes for the Control of Coronaviruses

Molecular Insights into Small-Molecule Drug Discovery for SARS-CoV-2

Perspectives on Nuclear Magnetic Resonance Spectroscopy in Drug Discovery Research

New techniques in antibiotic discovery and resistance: Raman spectroscopy

Plasmonic Imaging of Multivalent NTD-Nucleic Acid Interactions for Broad-Spectrum Antiviral Drug Analysis

Structure-based drug design: NMR-based approach for ligand-protein interactions.

Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (Mpro) by using STD-NMR spectroscopy, in silico studies and antiviral assays

Utilizing artificial intelligence for precision exploration of N protein targeting phenanthridine sars-cov-2 inhibitors: A novel approach

Development of a new experimental NMR strategy for covalent cysteine protease inhibitors screening: toward enhanced drug discovery

Going Retro, Going Viral: Experiences and Lessons in Drug Discovery from COVID-19

Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors

Structural basis of paramyxo- and pneumovirus polymerase inhibition by non-nucleoside small-molecule antivirals

Nuclear Magnetic Resonance Spectroscopy for Quantitative Analysis: A Review for Its Application in the Chemical, Pharmaceutical and Medicinal Domains